Tender For supply of pilocarpine nitrate eye solution 2 percent bott of 5ml eye drop , pilocarpine intracameral inj 0 point 5 percent pilocarpine nitrate intra ocular inj without preservatives amp of 01ml each , povidone 5 percent eye drop bott of 5ml , prednisolone acetate 1 percent w per v bott of 5ml , sodium chloride 6 percent w per w ointment tube of 3gm , sodium chloride eye drops 5 percent 5ml bott , timolol maleate eye drop 0 point 5 percent bott of 5ml , tobramycin 0 point 3 percent bott of 5ml , trypan blue 0 point 6 percent in vial of 1ml inj , bimatoprost 0 point 03 percent bott of 3ml , paracetamol 650mg tab , montelukast 10mg and levocetrizine 5mg combination tab , luliconazole 1 percent cream tube of 20gm , tab olanzapine 5mg , tab s adenosyl methionine 400mg , levodopa 250mg with carbidopa 25mg tab
Tender For supply of drugs - dept of opthal, interferon alfa 2b 3mu inj, inj chondroitin sodium 40 mg, sodium hyaluronate 30 mg, 0.75 ml preloaded syringe with cannula (sterile), inj lyophilized green powder containing 25mg of indocyanine green, fluoresceine sodium 20%, 3 ml inj, brilliant blue g 0.025% inj in sterile solution, trypan blue 0.6% in vial of 1ml inj, inj triamcinolone acetonide preservative free for intra ocular inj 40mg, intraocular gas c3f8 complete kit: 1. sealed envelope containing the 50ml bottle and 0.22, millipore filter with plug adapter for the canister. the ocuter envelope is sterilized with ethylene oxide. 2. sterile syringe (ce marked);each ml marking should be, intraocular gas sf6. intraocular gas sf6.with complete kit a kit includes:1:sealed envelope containing the 50ml bottle and 0.22, millipore filter with plug adapter for the canister.the ocuter envelope is sterilized withethylene oxide 2 sterile syrin., inj tropicamide 0.2% + phenylpherine 0.31% + lidocaine 1%, hydroxypropyl methyl cellulose 2% in pre-filled glass syringe, hyaluronidasee1500iu powder for injection inj, pilocarpine intracameral inj 0.5% pilocarpine nitrate intra-ocular inj without preservatives, amp of 01ml each, adrenaline preservative free vial for intracameral use, balanced salt solution in non toxic disposable plastic bott of 500 ml ffs or equivalent technology should withstand 60 mm of hg forced infusion pressure, perfluoro carbon liquid (pfcl) vial of 5ml
Tender For corrigendum : supply of sch i (supply of injections & sera vaccines) - sch i (supply of injections & sera vaccines), inj. b complex for prophylactic use vit. c 150 mg vit. b 12 2500 mcg folic acid 0.7 mg niacinamide 12 mg, inj. b complex for therapeutic use each ml contain vit a 1000 iu cholecalciferol 100 iu alphatochopherol acetate 0.5 mg. thiamine 5 mg. pyridoxine 0.5 mg. nicotinamide 10 mg. ascorbic acid 50 mg. d-panthenol 2.5 mg., inj. calcium gluconate 10% iv use., inj. desferroxamine 500 mg, inj. digoxin 0.5 mg iv use, inj. diltiazem 5 mg/ml, inj. fluconazole 200 mg. in plastic bottle, inj. fluorescein sodium (20%), inj. hydralazine 20 mg. iv, inj. hyaluronidase 1500 iu, inj. insulin plain (purified human) 40 units/ml sc/iv use (insulin plain and insulin nph/ lente should be of the same manufacturer and their rate will be considered as a unit.), inj.insulin nph/isophane40 iu (highly purified bovine porcine isophane insulin susp 40 i.u./ml nph insulin (or neutral protamine hagedorn)., inj. isoxsuprine hcl 10 mg/ml., intravenous injection of n (2)-l alanyl-l glutamine 20%, solution 50 ml, iv lipid 20% for neo-natal use., inj.lorazepam 2 mg/ml im/iv use., inj. l-ornithine l-aspartate 5 gm, inj. n-butyl cyanoacrylate 0.5 gm., inj. methylene blue 10 mg/ml, inj. metoprolol 5mg, nitroglycerine lingual spray in ready to use formulation. each spray should deliver 0.35 to 0.4 mg/spray 60-70 lit/spray., inj. phenobarbitone sodium 200 mg iv use, inj. protamine sulphate 1% iv use, inj. somatostatin 3 mg /vial, sterile & pyrogen free water for injection i.p 5ml, inj.sterile & pyrogen free water for injections i. p. 10 ml, inj. thiamine 100 mg/ml, inj. tricort triamcinolone sodium 10 mg, inj. tuberculine p. p. d. 5 t. u./0.1 ml intradermal use., inj. vit. k 10 mg/ml (aqueous) i. m./i. v., inj. valethamate bromide 8 mg, inj. benzathine penicillin 6 lacs unit for im use, inj. benzathine penicillin 12 lacs unit im use, inj. benzyl penicillin/ penicillin g/ crystalline penicillin salt 1000000 units/bulbs i. m./i. v., inj. ofloxacin 200 mg, inj. streptomycin sulphate 0.75 gm, inj. anti d 300 microgram/dose polyclonal/monoclonal, inj. diptheria antitoxin 10000 iu, inj. hepatitis b vaccine recombinant dna technology 20 mcg/ml, inj. hib vaccine 10 mcg. haemophilus influenza type b. polysacchride conjugate vaccine. [powder to be reconstituted with 0.5 ml diluent (saline)]., inj. human rabies immunoglobulin 150 i.u./ml, inj meningococcal conjugate vaccine single dose vial containing (a, c, y & w 135) polysaccharide conjugated to diptheria toxoid protein carrier., inj. mmr vaccine (measles, mumps & rubella) single dose im or sc., inj. pneumovax (pneumococcal 23 valent vaccine), inj. polyvalent antisnake venom serum- should contain equivalent of 10 ml of purified globulins 1 ml of reconstituted serum to neutralizes 0.5 mg to 0.6 mg of dried cobra venom, 0.45 mg of dried common krait venom, 0.6 mg. of dried russells viper venom, 0.45 mg of dried saw scaled viper venom, liquid or powder form will be accepted, inj. rabies human monoclonal antibody (rdna) 40 iu/ml., inj. tetanus vaccine purified toxoid adsorbed i. p. 5 lf./0.5ml, inj. tetanus immunoglobulin (human) 250 i. u. im / intrathecal use., inj. tetanus immunoglobulin (human) 500 i. u. im / intrathecal use., inj. lignocaine 10% spray, inj. propofol 1% mct/lct fat emulsion with sodium oleate 50 ml, inj. ropivacaine hcl 0.5%, inj. 2% hydroxypropyl methyl cellulose preservative free sterile for intraocular use during cataract surgery in sterile prefilled syringe & with sterile cannula., intracameral injection lignocaine hydrochloride 1%, inj. perfluoro-n-octane liquid for intraocular use sterile, inj. pilocarpine (0.5%) nitrate/hcl sterile opthalmic solution for injection., inj. silicon oil for (polydimethyl siloxane for intraocular use) sterile viscosity 1500 mm2/s cst, inj. sodium hyaluronate 1.4%, inj. sodium hyaluronate 1.8%, inj. continuous ambulatory peritoneal d